Vitamin B6 (P5P) vs Vitamin D3

Mechanism

Pyridoxal-5-phosphate (P5P) is the active coenzyme form of vitamin B6, required by over 150 enzymes. Key roles: transamination and decarboxylation of amino acids, serving as a cofactor for aromatic L-amino acid decarboxylase (converting 5-HTP to serotonin and L-DOPA to dopamine), glutamic acid decarboxylase (producing GABA), cystathionine beta-synthase (homocysteine transsulfuration to cysteine), serine hydroxymethyltransferase (one-carbon folate metabolism), glycogen phosphorylase (glycogenolysis), and aminolevulinic acid synthase (heme synthesis).

Standard Dosing

25-50mg P5P daily

Timing

Morning with food. Often included in B-complex.

Cycle Duration

ongoing

Side Effects

• Peripheral neuropathy at chronic doses >200mg/day (numbness, tingling)
• Photosensitivity
• Nausea
• Vivid dreams

Contraindications

• Levodopa monotherapy
• Doses >200mg/day chronically (peripheral neuropathy risk)

Best Stacking Partners

Mechanism

Vitamin D3 (cholecalciferol) is hydroxylated in the liver to 25(OH)D (calcidiol), then in the kidneys to 1,25(OH)2D (calcitriol), the active hormone. Calcitriol binds the nuclear vitamin D receptor (VDR), forming a heterodimer with RXR that regulates >1000 genes. Key actions: upregulation of intestinal calcium/phosphorus absorption (TRPV6, calbindin), modulation of innate immunity (cathelicidin LL-37 antimicrobial peptide production), suppression of adaptive immune overactivation (Th1/Th17 to Treg shift), regulation of PTH and osteocalcin for bone mineralization, and modulation of insulin secretion from beta cells.

Standard Dosing

5000 IU daily (125 mcg)

Timing

With largest fat-containing meal of the day (fat-soluble). Morning preferred.

Cycle Duration

ongoing (lifelong for most people in northern latitudes)

Side Effects

• Hypercalcemia at excessive doses (>10,000 IU/day long-term without monitoring)
• Nausea/vomiting (toxicity)
• Kidney stones (with excessive calcium)
• Metallic taste (toxicity sign)

Contraindications

• Hypercalcemia
• Granulomatous diseases (sarcoidosis, some lymphomas — unregulated 1-alpha hydroxylase conversion)
• Primary hyperparathyroidism (without monitoring)
• Williams syndrome

Best Stacking Partners